申请人:Laali Kenneth K.
公开号:US20180362433A1
公开(公告)日:2018-12-20
Novel CUR- and CUR-BF
2
compounds exhibiting anti-tumor properties are presented. CUR compounds bearing fluorinated moieties with selective fluorine introduction into the α-carbonyl moiety as well as CUR-BF
2
adducts and CURs with diverse substitution patterns in the phenyl rings including fluorinated substituents (SCF
3
, OCF
3
, and F) and/or bulky activating groups (OMe, OAc, and OBz) are presented. Fluorinated aryl-pyrazoles and isoxazoles as well as novel CUR and CUR-BF
2
compounds with monocyclic aromatic and bicyclic-heteroaromatic lateral rings, bearing fluorine(s), OCF3, CF3, and SCF3 groups, and their alpha-carbonyl-fluorinated analogs, as well as their pyrazole and isoxazole derivatives are presented. The CUR-pyrazoles embody analogs that are fluorinated at the phenyl-pyrazole moiety. The compounds and their derivatives exhibited exceptional cytotoxic and anti-proliferative activity against several cancer cell-lines. Deuterated CUR-BF2 and CUR compounds were also synthesized.
展示了具有抗肿瘤特性的新型CUR-和CUR-BF2化合物。这些CUR化合物带有氟化基团,选择性地将氟引入α-羰基部位,以及具有不同苯环取代模式的CUR-BF2加合物和CURs,包括氟取代基团(SCF3,OCF3和F)和/或体积庞大的活化基团(OMe,OAc和OBz)。展示了氟化芳基吡唑和异噁唑,以及具有单环芳香和双环杂芳侧链的新型CUR和CUR-BF2化合物,带有氟(s),OCF3,CF3和SCF3基团,以及它们的α-羰基-氟化类似物,以及它们的吡唑和异噁唑衍生物。CUR-吡唑体现了在苯基吡唑部位氟化的类似物。这些化合物及其衍生物对几种癌细胞系表现出出色的细胞毒性和抗增殖活性。还合成了氘代CUR-BF2和CUR化合物。